Peroxisome proliferator-activated receptor (PPAR) agonists decrease lipoprotein lipase secretion and glycated LDL uptake by human macrophages.
Lipoprotein lipase (LPL) acts independently of its function as triglyceride hydrolase by stimulating macrophage binding and uptake of native, oxidized and glycated LDL. Peroxisome proliferator-activated receptors (PPARs) are nuclear receptors expressed in monocyte/macrophages, where they control cholesterol homeostasis. Here we study the role of PPARs in the regulation of LPL expression and activity in human monocytes and macrophages. Incubation of human monocytes or macrophages with PPARalpha or PPARgamma ligands increases LPL mRNA and intracellular protein levels. By contrast, PPAR activators decrease secreted LPL mass and enzyme activity in differentiated macrophages. These actions of PPAR activators are associated with a reduced uptake of glycated LDL and could influence atherosclerosis development associated with diabetes.
Gbaguidi
F G
FG
UR. 545 INSERM and Université de Lille 2, Lille, France.
Chinetti
G
G
Milosavljevic
D
D
Teissier
E
E
Chapman
J
J
Olivecrona
G
G
Fruchart
J C
JC
Griglio
S
S
Fruchart-Najib
J
J
Staels
B
B
D001692:Biological Transport; D002454:Cell Differentiation; D017127:Glycation End Products, Advanced; D006801:Humans; D008071:Lipoprotein Lipase / Q000378:metabolism*; D008077:Lipoproteins, LDL / Q000378:metabolism*; D008264:Macrophages / Q000166:cytology / Q000378:metabolism*; D009000:Monocytes / Q000166:cytology / Q000378:metabolism*; D018160:Receptors, Cytoplasmic and Nuclear / Q000819:agonists*; D014157:Transcription Factors / Q000819:agonists*; D000093844:Glycated Proteins
D017127:Glycation End Products, Advanced; D008071:Lipoprotein Lipase; D008077:Lipoproteins, LDL; D018160:Receptors, Cytoplasmic and Nuclear; D014157:Transcription Factors; C031797:glycated lipoproteins, LDL; D000093844:Glycated Proteins